Tempus AI, Inc. Class A Common Stock (TEM) is a publicly traded Healthcare sector company. As of October 3, 2026, TEM trades at $76.69 with a market cap of $13.89B and a P/E ratio of -53.22. TEM moved +0.21% today. Year to date, TEM is +22.88%; over the trailing twelve months it is -14.19%. Its 52-week range spans $36.22 to $104.32. Analyst consensus is buy with an average price target of $67.88. Rallies surfaces TEM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Tempus AI says 13 clinical research abstracts win ESMO 2026 presentation slots: Tempus AI said 13 cancer research abstracts were accepted for presentation at the ESMO Congress 2026 in Madrid, scheduled for Oct. 23-27.
| Metric | Value |
|---|---|
| Price | $76.69 |
| Market Cap | $13.89B |
| P/E Ratio | -53.22 |
| EPS | $-1.44 |
| Dividend Yield | 0.44% |
| 52-Week High | $104.32 |
| 52-Week Low | $36.22 |
| Volume | 4.22M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.43B |
| Net Income | $-254.43M |
| Gross Margin | 0.00% |
18 analysts cover TEM: 0 strong buy, 10 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $67.88.